微血管性溶血合并血小板减少在急诊的思考

朱继红; 石茂静; 高伟波

doi:10.13201/j.issn.1009-5918.2018.09.002

微血管性溶血合并血小板减少在急诊的思考

- 北京大学人民医院急诊科(北京, 100044)

详细信息

通讯作者: 朱继红,E-mail:zhujihong64@sina.com

中图分类号: R556.6

收稿日期: 2018-07-25

Microvascular hemolysis combined with thrombocytopenia in emergency department

More Information

Corresponding author: , E-mail: zhujihong64@sina.com

Received Date: 25 July 2018

摘要

- 血栓性血小板减少性紫癜 /
- 鉴别诊断 /
- ADAMTS13 /
- 外周血涂片
Abstract: Thrombotic thrombocytopenic purpura (TTP) needs to be considered when microvascular hemolytic anemia combined with thrombocytopenia, and active treatment should be taken as soon as possible to reduce the mortality of TTP.However, due to the complexity of the emergency department, it is necessary to identify the pseudo-TTP caused by systemic diseases to avoid unnecessary treatment.The PLASMIC scoring system can assist in the diagnosis of TTP because the ADAMTS13 activity can not be obtained immediately.In addition, peripheral blood smears and LDH values also contribute to diagnosis.
- thrombotic thrombocytopenic purpura /
- differential diagnosis /
- ADAMTS13 /
- peripheral blood smears

HTML全文

参考文献(31)

[1]	Walter K, Vaughn J, Martin D.Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency[J].BMC Hematol, 2015, 15 (1):15-16.
[2]	Blombery P, Kivivali L, Pepperell D, et al.TTP registry steering committee.Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia:findings from the first 5years of the Australian TTP/thrombotic microangiopathy registry[J].Intern Med J, 2016, 46 (1):71-79.
[3]	Mariotte E, Azoulay E, Galicier L, et al.French Reference Center for Thrombotic Microangiopathies.Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura):a cross-sectional analysis of the French national registry for thrombotic microangiopathy[J].Lancet Haematol, 2016, 3 (5):e237-e245.
[4]	Martino S, Jamme M, Deligny C, et al.French Reference Center for ThromboticMicroangiopathies.Thromboticthrombocytopenic purpura in black people:impact of ethnicity on survival and genetic risk factors[J].PLoS One, 2016, 11 (7):e0156679.
[5]	中华医学会血液学分会血栓与止血组.血栓性血小板减少性紫癜诊断与治疗中国专家共识 (2012年版)[J].中华血液学杂志, 2012, 33 (11):983-984.
[6]	Rogers H J, Allen C, Lichtin A E.Thrombotic thrombocytopenic purpura:The role of ADAMTS13 [J].Cleve Clin J Med, 2016, 83 (8):597-603.
[7]	Barrows B D, Teruya J.Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura[J].Arch Pathol Lab Med, 2014, 138 (4):546-549.
[8]	George J N.Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura:when, how, and why?[J].Transfusion, 2015, 55 (1):11-13.
[9]	Page E E, Kremer Hovinga J A, Terrell D R, et al.Thrombotic thrombocytopenic purpura:diagnostic criteria, clinical features, and long-term outcomes from 1995through 2015[J].Blood Adv, 2017, 1 (10):590-600.
[10]	George J N, Chen Q, Deford C C, et al.Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency[J].J Clin Apher, 2012, 27 (6):302-311.
[11]	Rieger M, Mannucci P M, Kremer Hovinga J A, et al.ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases[J].Blood, 2005, 106 (6):1262-1267.
[12]	Kremer Hovinga J A, Vesely S K, Terrell D R, et al.Survival and relapse in patients with thrombotic thrombocytopenic purpura[J].Blood, 2010, 115 (8):1500-1511.
[13]	Dimond A, George J N, Hastings C.Severe vitamin B-12deficiency in a child mimicking thrombotic thrombocytopenia purpura[J].Pediatr Blood Cancer, 2009, 52 (3):420-422.
[14]	Jamme M, Rondeau E.The PLASMIC score for thrombotic thrombocytopenic purpura[J].Lancet Haematol, 2017, 4 (4):e148-e149.
[15]	Bendapudi P K, Hurwitz S, Fry A, et al.Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies:a cohort study[J].Lancet Haematol, 2017, 4 (4):e157-e164.
[16]	Li A, Khalighi P R, Wu Q, et al.External validation of the PLASMIC score:a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment[J].J Thromb Haemost, 2018, 16 (1):164-169.
[17]	Risam S.Management of hemolytic-uremic syndrome in children[J].Int J NephrolRenovasc Dis, 2014, 7:231-239.
[18]	Allen L H.How common is vitamin B-12deficiency?[J].Am J Clin Nutr, 2009, 89 (2):693S-696S.
[19]	Hunt A, Harrington D, Robinson S.Vitamin B12 deficiency[J].BMJ, 2014, 349:g5226.
[20]	Andres E, Affenberger S, Zimmer J, et al.Current hematological findings in cobalamin deficiency.A study of 201consecutive patients with documented cobalamin deficiency[J].Clin Lab Haematol, 2006, 28 (1):50-56.
[21]	Asano T, Narazaki H, Kaizu K, et al.Neglect-induced pseudo-thrombotic thrombocytopenic purpura due to vitamin B12 deficiency[J].Pediatr Int, 2015, 57 (5):988-990.
[22]	Abbott D W, Friedman K D, Karafin M S.Differentiation of pernicious anemia from thrombotic thrombocytopenic purpura:The clinical value of subtle pathologic findings[J].Transfus Apher Sci, 2016, 55 (3):318-322.
[23]	Malla M, Seetharam M.To treat or not to treat:a rare case of pseudo-thrombotic thrombocytopenic purpura in a Jehovah's Witness[J].Transfusion, 2016, 56 (1):160-163.
[24]	Routh J K, Koenig S C.Severe vitamin B12 deficiency mimicking thrombotic thrombocytopenic purpura[J].Blood, 2014, 124 (11):1844.
[25]	Lee Y J, Wang M Y, Lin M C, et al.Associations between vitamin B-12status and oxidative stress and inflammation in diabetic vegetarians and omnivores[J].Nutrients, 2016, 8 (3):118.
[26]	Bernardo A, Ball C, Nolasco L, et al.Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow[J].Blood, 2004, 104 (1):100-106.
[27]	Noel N, Maigne G, Tertian G, et al.Hemolysis and schistocytes in the emergency department:consider pseudothrombotic microangiopathy related to B12 deficiency[J].Q J Med, 2013, 106 (11):1017-1022.
[28]	施小凤, 傅晋翔, 朱彦, 等.乳酸脱氢酶、羟丁酸脱氢酶检测在巨幼细胞性贫血诊治中的意义[N].苏州大学学报 (医学版), 2009, 29 (6):1179-1181.
[29]	吴海兵, 郭晓珺, 季素芳, 等.动态检测血清乳酸脱氢酶在骨髓增生异常综合征和巨幼细胞性贫血诊断中的意义[J].临床内科杂志, 2008, 25 (9):646.
[30]	McCrae K R, Sadler E, Cines D B.Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.In:Hematology:basic principles and practice[M].6th ed.Philadelphia P A:Elsevier, 2013:1925-1939.
[31]	Bell W R, Braine H G, Ness P M, et al.Improved survival in thromboticthrombocytopenic purpura-hemolytic uremicsyndrome.Clinical experience in 108patients[J].NEngl J Med, 1991, 325 (6):398-403.